Bendamustine Hydrochloride in Treating Patients With Previously Treated Multiple Myeloma
Status:
Withdrawn
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This phase I trial studies the side effects and best dose of bendamustine hydrochloride in
treating patients with previously treated multiple myeloma. Drugs used in chemotherapy, such
as bendamustine hydrochloride, work in different ways to stop the growth of cancer cells,
either by killing the cells, by stopping them from dividing, or by stopping them from
spreading.
Phase:
Phase 1
Details
Lead Sponsor:
Sidney Kimmel Cancer Center at Thomas Jefferson University